至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Generation of a Soluble African Horse Sickness Virus VP7 Protein Capable of Forming Core-like Particles

Viruses. 2022-07; 
Shani Bekker, Henk Huismans, Vida van Staden
Products/Services Used Details Operation
Polyclonal Antibody Services … A primary antibody against AHSV VP3 was produced in rabbits by GenScript Biotech Corp (Piscataway, NJ, USA) (complete affinity-purified peptide polyclonal antibody) and diluted 1:… Get A Quote

摘要

A unique characteristic of the African horse sickness virus (AHSV) major core protein VP7 is that it is highly insoluble, and spontaneously forms crystalline particles in AHSV-infected cells and when expressed in vitro. The aggregation of AHSV VP7 into these crystals presents many problems in AHSV vaccine development, and it is unclear whether VP7 aggregation affects AHSV assembly or contributes to AHSV pathogenesis. Here, we set out to abolish VP7 self-assembly by targeting candidate amino acid regions on the surface of the VP7 trimer via site-directed mutagenesis. It was found that the substitution of seven amino acids resulted in the complete disruption of AHSV VP7 self-assembly, which abolished the formatio... More

关键词

African horse sickness virus, VP7, core-like particle, crystalline particle, equine, mutagenesis, solubility, vaccine, virus-like particle